Natera
NTRA
#689
Rank
HK$263.12 B
Marketcap
HK$1,906
Share price
1.17%
Change (1 day)
40.75%
Change (1 year)

P/E ratio for Natera (NTRA)

P/E ratio as of December 2025 (TTM): -113

According to Natera's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -113.112. At the end of 2023 the company had a P/E ratio of -16.6.

P/E ratio history for Natera from 2015 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2023-16.6129.78%
2022-7.21-59.66%
2021-17.9-48.63%
2020-34.885.81%
2019-18.7221.12%
2018-5.8366.11%
2017-3.51-44.22%
2016-6.3052%
2015-4.14

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Prothena
PRTA
-2.14-98.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Paratek Pharmaceuticals
PRTK
-2.03-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
31.9-128.22%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.